No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Both dermatologists and patients with psoriatic disease expressed positive perspectives on strategies to improve cardiovascular disease prevention

byKathleen Lau

January 28, 2022

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis

2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

Convalescent plasma is not effective at improving clinical outcomes or reducing mortality of COVID-19 patients not on mechanical ventilation

RelatedReports

Brodalumab effective in treating active psoriatic arthritis

Chronic Disease

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis

June 5, 2026

Pharma

2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis

June 3, 2026

Psychiatry

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

April 30, 2026

Eczema more prevalent among older adults than previously thought

Cardiology

Atopic dermatitis activity is not associated with cardiovascular risk

April 2, 2026

Total knee replacement with post-surgical regimen yields greater relief vs nonsurgical treatment alone

2 Minute Medicine Rewind January 31, 2022

2 Minute Medicine Rewind October 14, 2019

Use of different sepsis scoring systems to predict mortality in bacteremic patients

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons

Intracranial efficacy of alectinib in ALK-positive non-small cell lung cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result